Unveiling the analytical insights into nitrosamine drug substance-related impurities (NDSRIs)

Join us for a webinar series on the critical topic of NDSRIs, specifically focusing on their analysis and implications in the pharmaceutical industry.

Nitrosamines, a class of potentially carcinogenic impurities, have gained significant attention in recent years due to their presence in certain drug substances. Understanding their analytical aspects is vital to ensure patient safety and compliance with regulatory guidelines. Let's explore the world of NDSRI analysis together!

The webinar will focus on the following:

• Understanding NDSRIs: an overview
• Analytical techniques for NDSRI detection and quantitation
• Regulatory landscape and compliance
• Case studies: NDSRI analysis in drug substances

Presenter: Dr. Pankaj Partani (Application Support Manager, SCIEX)

Dr. Pankaj is a seasoned professional with over 15 years of experience in the field of bioanalytical method development and validation. His expertise extends to quantitation of genotoxic impurities and impurity profiling, pharmaceutics, and biopharmaceuticals. He is well-versed in small molecule analysis and has a proven track record of delivering accurate and reliable results.